0001415889-24-005957.txt : 20240229
0001415889-24-005957.hdr.sgml : 20240229
20240229181418
ACCESSION NUMBER: 0001415889-24-005957
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weaver Erik
CENTRAL INDEX KEY: 0001923538
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40887
FILM NUMBER: 24705775
MAIL ADDRESS:
STREET 1: C/O ORTHO-CLINICAL DIAGNOSTICS, INC.
STREET 2: 1001 ROUTE 202
CITY: RARITAN
STATE: NJ
ZIP: 08869
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Life Time Group Holdings, Inc.
CENTRAL INDEX KEY: 0001869198
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEMBERSHIP SPORTS & RECREATION CLUBS [7997]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 473481985
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2902 CORPORATE PLACE
CITY: CHANHASSEN
STATE: MN
ZIP: 55317
BUSINESS PHONE: (952) 947-0000
MAIL ADDRESS:
STREET 1: 2902 CORPORATE PLACE
CITY: CHANHASSEN
STATE: MN
ZIP: 55317
4
1
form4-02292024_110210.xml
X0508
4
2024-02-27
0001869198
Life Time Group Holdings, Inc.
LTH
0001923538
Weaver Erik
C/O LIFE TIME GROUP HOLDINGS, INC.
2902 CORPORATE PLACE
CHANHASSEN
MN
55317
false
true
false
false
SVP, INTERIM CFO & CONTROLLER
1
Common Stock
2024-02-27
4
A
0
15000
0
A
92236
D
Common Stock
2024-02-28
4
S
0
5269
12.77
D
86967
D
Common Stock
2024-02-29
4
S
0
20579
14.0103
D
66388
D
Reflects 15,000 shares of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in three equal annual installments beginning on February 1, 2025.
The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.
Reflects the weighted average price of 20,579 shares of common stock of Life Time Group Holdings, Inc. sold by the reporting person in multiple transactions on February 29, 2024 with sale prices ranging from $14.00 to $14.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Stuart McFarland, Attorney-in-fact
2024-02-29